Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 128

1.

Maintenance Olaparib for Metastatic Pancreatic Cancer. Reply.

Golan T, Locker GY, Kindler HL.

N Engl J Med. 2019 Oct 10;381(15):1492-1493. doi: 10.1056/NEJMc1911185. No abstract available.

PMID:
31597029
2.

Health-related quality of life in patients with a germline BRCA mutation and metastatic pancreatic cancer receiving maintenance olaparib.

Hammel P, Kindler HL, Reni M, Cutsem EV, Macarulla T, Hall MJ, Park JO, Hochhauser D, Arnold D, Oh DY, Reinacher-Schick A, Tortora G, Algül H, O'Reilly EM, McGuinness D, Cui KY, Joo S, Yoo HK, Patel N, Golan T.

Ann Oncol. 2019 Sep 28. pii: mdz406. doi: 10.1093/annonc/mdz406. [Epub ahead of print]

PMID:
31562758
3.

Acute vascular events as a possibly related adverse event of immunotherapy: a single-institute retrospective study.

Bar J, Markel G, Gottfried T, Percik R, Leibowitz-Amit R, Berger R, Golan T, Daher S, Taliansky A, Dudnik E, Shulman K, Urban D, Onn A.

Eur J Cancer. 2019 Oct;120:122-131. doi: 10.1016/j.ejca.2019.06.021. Epub 2019 Sep 10.

PMID:
31518968
4.

Abemaciclib Is Effective Against Pancreatic Cancer Cells and Synergizes with HuR and YAP1 Inhibition.

Dhir T, Schultz CW, Jain A, Brown SZ, Haber A, Goetz A, Xi C, Su GH, Xu L, Posey J 3rd, Jiang W, Yeo CJ, Golan T, Pishvaian MJ, Brody JR.

Mol Cancer Res. 2019 Oct;17(10):2029-2041. doi: 10.1158/1541-7786.MCR-19-0589. Epub 2019 Aug 5.

PMID:
31383722
5.

Adipocytes sensitize melanoma cells to environmental TGF-β cues by repressing the expression of miR-211.

Golan T, Parikh R, Jacob E, Vaknine H, Zemser-Werner V, Hershkovitz D, Malcov H, Leibou S, Reichman H, Sheinboim D, Percik R, Amar S, Brenner R, Greenberger S, Kung A, Khaled M, Levy C.

Sci Signal. 2019 Jul 23;12(591). pii: eaav6847. doi: 10.1126/scisignal.aav6847.

PMID:
31337739
6.

Lung Metastasis Predicts Better Prognosis in Metastatic Colorectal Cancer With Mutated KRAS.

Margalit O, Shacham-Shmueli E, Lawrence YR, Yang YX, Reiss KA, Golan T, Mamtani R, Halpern N, Aderka D, Giantonio B, Boursi B.

Clin Colorectal Cancer. 2019 Sep;18(3):e300-e307. doi: 10.1016/j.clcc.2019.06.001. Epub 2019 Jun 26.

PMID:
31324478
7.

Poly (ADP) Ribose Glycohydrolase Can Be Effectively Targeted in Pancreatic Cancer.

Jain A, Agostini LC, McCarthy GA, Chand SN, Ramirez A, Nevler A, Cozzitorto J, Schultz CW, Lowder CY, Smith KM, Waddell ID, Raitses-Gurevich M, Stossel C, Gorman YG, Atias D, Yeo CJ, Winter JM, Olive KP, Golan T, Pishvaian MJ, Ogilvie D, James DI, Jordan AM, Brody JR.

Cancer Res. 2019 Sep 1;79(17):4491-4502. doi: 10.1158/0008-5472.CAN-18-3645. Epub 2019 Jul 4.

PMID:
31273064
8.

Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer.

Golan T, Hammel P, Reni M, Van Cutsem E, Macarulla T, Hall MJ, Park JO, Hochhauser D, Arnold D, Oh DY, Reinacher-Schick A, Tortora G, Algül H, O'Reilly EM, McGuinness D, Cui KY, Schlienger K, Locker GY, Kindler HL.

N Engl J Med. 2019 Jul 25;381(4):317-327. doi: 10.1056/NEJMoa1903387. Epub 2019 Jun 2.

PMID:
31157963
9.

Postoperative Radiation for Pathologic Stage T4 Colon Cancers Receiving Adjuvant Chemotherapy.

Margalit O, Mamtani R, Lawrence YR, Yang YX, Reiss KA, Golan T, Halpern N, Aderka D, Giantonio B, Shacham-Shmueli E, Boursi B.

Clin Colorectal Cancer. 2019 Sep;18(3):226-230.e2. doi: 10.1016/j.clcc.2019.04.004. Epub 2019 Apr 13.

PMID:
31097386
10.

Locally advanced rectal adenocarcinoma: Are preoperative short and long course radiotherapy truly equivalent?

Margalit O, Mamtani R, Lawrence YR, Yang YX, Baruch EN, Reiss KA, Golan T, Halpern N, Aderka D, Giantonio B, Shacham-Shmueli E, Boursi B.

Mol Clin Oncol. 2019 May;10(5):555-559. doi: 10.3892/mco.2019.1825. Epub 2019 Mar 14.

11.

Neural network models and deep learning.

Kriegeskorte N, Golan T.

Curr Biol. 2019 Apr 1;29(7):R231-R236. doi: 10.1016/j.cub.2019.02.034.

PMID:
30939301
12.

Pembrolizumab alone or in combination with chemotherapy as first-line therapy for patients with advanced gastric or gastroesophageal junction adenocarcinoma: results from the phase II nonrandomized KEYNOTE-059 study.

Bang YJ, Kang YK, Catenacci DV, Muro K, Fuchs CS, Geva R, Hara H, Golan T, Garrido M, Jalal SI, Borg C, Doi T, Yoon HH, Savage MJ, Wang J, Dalal RP, Shah S, Wainberg ZA, Chung HC.

Gastric Cancer. 2019 Jul;22(4):828-837. doi: 10.1007/s10120-018-00909-5. Epub 2019 Mar 25.

13.

Real-Time Targeted Genome Profile Analysis of Pancreatic Ductal Adenocarcinomas Identifies Genetic Alterations That Might Be Targeted With Existing Drugs or Used as Biomarkers.

Singhi AD, George B, Greenbowe JR, Chung J, Suh J, Maitra A, Klempner SJ, Hendifar A, Milind JM, Golan T, Brand RE, Zureikat AH, Roy S, Schrock AB, Miller VA, Ross JS, Ali SM, Bahary N.

Gastroenterology. 2019 Jun;156(8):2242-2253.e4. doi: 10.1053/j.gastro.2019.02.037. Epub 2019 Mar 2.

14.

Negative Regulatory Loop between Microphthalmia-Associated Transcription Factor (MITF) and Notch Signaling.

Golan T, Levy C.

Int J Mol Sci. 2019 Jan 29;20(3). pii: E576. doi: 10.3390/ijms20030576.

15.

Refining the Use of Adjuvant Oxaliplatin in Clinical Stage II or III Rectal Adenocarcinoma.

Margalit O, Mamtani R, Kopetz S, Yang YX, Lawrence YR, Abu-Gazala S, Reiss KA, Golan T, Halpern N, Aderka D, Giantonio B, Shacham-Shmueli E, Boursi B.

Oncologist. 2019 Aug;24(8):e671-e676. doi: 10.1634/theoncologist.2018-0333. Epub 2019 Jan 29.

PMID:
30696723
16.

Integration of Genomic and Transcriptional Features in Pancreatic Cancer Reveals Increased Cell Cycle Progression in Metastases.

Connor AA, Denroche RE, Jang GH, Lemire M, Zhang A, Chan-Seng-Yue M, Wilson G, Grant RC, Merico D, Lungu I, Bartlett JMS, Chadwick D, Liang SB, Eagles J, Mbabaali F, Miller JK, Krzyzanowski P, Armstrong H, Luo X, Jorgensen LGT, Romero JM, Bavi P, Fischer SE, Serra S, Hafezi-Bakhtiari S, Caglar D, Roehrl MHA, Cleary S, Hollingsworth MA, Petersen GM, Thayer S, Law CHL, Nanji S, Golan T, Smith AL, Borgida A, Dodd A, Hedley D, Wouters BG, O'Kane GM, Wilson JM, Zogopoulos G, Notta F, Knox JJ, Gallinger S.

Cancer Cell. 2019 Feb 11;35(2):267-282.e7. doi: 10.1016/j.ccell.2018.12.010. Epub 2019 Jan 24.

PMID:
30686769
17.

Publisher's Note: Identification of Nuclear Effects in Neutrino-Carbon Interactions at Low Three-Momentum Transfer [Phys. Rev. Lett. 116, 071802 (2016)].

Rodrigues PA, Demgen J, Miltenberger E, Aliaga L, Altinok O, Bellantoni L, Bercellie A, Betancourt M, Bodek A, Bravar A, Budd H, Cai T, Carneiro MF, Chvojka J, Devan J, Dytman SA, Díaz GA, Eberly B, Elkins M, Felix J, Fields L, Fine R, Gago AM, Galindo R, Gallagher H, Ghosh A, Golan T, Gran R, Harris DA, Higuera A, Hurtado K, Kiveni M, Kleykamp J, Kordosky M, Le T, Leistico JR, Lovlein A, Maher E, Manly S, Mann WA, Marshall CM, Martinez Caicedo DA, McFarland KS, McGivern CL, McGowan AM, Messerly B, Miller J, Mislivec A, Morfín JG, Mousseau J, Muhlbeier T, Naples D, Nelson JK, Norrick A, Nuruzzaman, Osta J, Paolone V, Patrick CE, Perdue GN, Ramirez MA, Ransome RD, Ray H, Ren L, Rimal D, Ruterbories D, Schellman H, Schmitz DW, Solano Salinas CJ, Tagg N, Tice BG, Valencia E, Walton T, Wolcott J, Wospakrik M, Zavala G, Zhang D; MINERvA Collaboration.

Phys Rev Lett. 2018 Nov 16;121(20):209902. doi: 10.1103/PhysRevLett.121.209902.

PMID:
30500228
18.

Search for CP Violation in Neutrino and Antineutrino Oscillations by the T2K Experiment with 2.2×10^{21} Protons on Target.

Abe K, Akutsu R, Ali A, Amey J, Andreopoulos C, Anthony L, Antonova M, Aoki S, Ariga A, Ashida Y, Azuma Y, Ban S, Barbi M, Barker GJ, Barr G, Barry C, Batkiewicz M, Bench F, Berardi V, Berkman S, Berner RM, Berns L, Bhadra S, Bienstock S, Blondel A, Bolognesi S, Bourguille B, Boyd SB, Brailsford D, Bravar A, Bronner C, Buizza Avanzini M, Calcutt J, Campbell T, Cao S, Cartwright SL, Catanesi MG, Cervera A, Chappell A, Checchia C, Cherdack D, Chikuma N, Christodoulou G, Coleman J, Collazuol G, Coplowe D, Cudd A, Dabrowska A, De Rosa G, Dealtry T, Denner PF, Dennis SR, Densham C, Di Lodovico F, Dokania N, Dolan S, Drapier O, Duffy KE, Dumarchez J, Dunne P, Emery-Schrenk S, Ereditato A, Fernandez P, Feusels T, Finch AJ, Fiorentini GA, Fiorillo G, Francois C, Friend M, Fujii Y, Fujita R, Fukuda D, Fukuda Y, Gameil K, Giganti C, Gizzarelli F, Golan T, Gonin M, Hadley DR, Haegel L, Haigh JT, Hamacher-Baumann P, Hansen D, Harada J, Hartz M, Hasegawa T, Hastings NC, Hayashino T, Hayato Y, Hiramoto A, Hogan M, Holeczek J, Hosomi F, Ichikawa AK, Ikeda M, Imber J, Inoue T, Intonti RA, Ishida T, Ishii T, Ishitsuka M, Iwamoto K, Izmaylov A, Jamieson B, Jiang M, Johnson S, Jonsson P, Jung CK, Kabirnezhad M, Kaboth AC, Kajita T, Kakuno H, Kameda J, Karlen D, Katori T, Kato Y, Kearns E, Khabibullin M, Khotjantsev A, Kim H, Kim J, King S, Kisiel J, Knight A, Knox A, Kobayashi T, Koch L, Koga T, Koller PP, Konaka A, Kormos LL, Koshio Y, Kowalik K, Kubo H, Kudenko Y, Kurjata R, Kutter T, Kuze M, Labarga L, Lagoda J, Lamoureux M, Lasorak P, Laveder M, Lawe M, Licciardi M, Lindner T, Liptak ZJ, Litchfield RP, Li X, Longhin A, Lopez JP, Lou T, Ludovici L, Lu X, Magaletti L, Mahn K, Malek M, Manly S, Maret L, Marino AD, Martin JF, Martins P, Maruyama T, Matsubara T, Matveev V, Mavrokoridis K, Ma WY, Mazzucato E, McCarthy M, McCauley N, McFarland KS, McGrew C, Mefodiev A, Metelko C, Mezzetto M, Minamino A, Mineev O, Mine S, Missert A, Miura M, Moriyama S, Morrison J, Mueller TA, Murphy S, Nagai Y, Nakadaira T, Nakahata M, Nakajima Y, Nakamura KG, Nakamura K, Nakamura KD, Nakanishi Y, Nakayama S, Nakaya T, Nakayoshi K, Nantais C, Nielsen C, Niewczas K, Nishikawa K, Nishimura Y, Nonnenmacher TS, Novella P, Nowak J, O'Keeffe HM, O'Sullivan L, Okumura K, Okusawa T, Oryszczak W, Oser SM, Owen RA, Oyama Y, Palladino V, Palomino JL, Paolone V, Paudyal P, Pavin M, Payne D, Pickering L, Pidcott C, Pinzon Guerra ES, Pistillo C, Popov B, Porwit K, Posiadala-Zezula M, Pritchard A, Quilain B, Radermacher T, Radicioni E, Ratoff PN, Reinherz-Aronis E, Riccio C, Rondio E, Rossi B, Roth S, Rubbia A, Ruggeri AC, Rychter A, Sakashita K, Sánchez F, Sasaki S, Scantamburlo E, Scholberg K, Schwehr J, Scott M, Seiya Y, Sekiguchi T, Sekiya H, Sgalaberna D, Shah R, Shaikhiev A, Shaker F, Shaw D, Shiozawa M, Smirnov A, Smy M, Sobczyk JT, Sobel H, Sonoda Y, Steinmann J, Stewart T, Stowell P, Suda Y, Suvorov S, Suzuki A, Suzuki SY, Suzuki Y, Sztuc AA, Tacik R, Tada M, Takeda A, Takeuchi Y, Tamura R, Tanaka HK, Tanaka HA, Thakore T, Thompson LF, Toki W, Touramanis C, Tsui KM, Tsukamoto T, Tzanov M, Uchida Y, Uno W, Vagins M, Vallari Z, Vasseur G, Vilela C, Vladisavljevic T, Volkov VV, Wachala T, Walker J, Wang Y, Wark D, Wascko MO, Weber A, Wendell R, Wilking MJ, Wilkinson C, Wilson JR, Wilson RJ, Wret C, Yamada Y, Yamamoto K, Yamasu S, Yanagisawa C, Yang G, Yano T, Yasutome K, Yen S, Yershov N, Yokoyama M, Yoshida T, Yu M, Zalewska A, Zalipska J, Zaremba K, Zarnecki G, Ziembicki M, Zimmerman ED, Zito M, Zsoldos S, Zykova A; T2K Collaboration.

Phys Rev Lett. 2018 Oct 26;121(17):171802. doi: 10.1103/PhysRevLett.121.171802.

19.

UV-Protection Timer Controls Linkage between Stress and Pigmentation Skin Protection Systems.

Malcov-Brog H, Alpert A, Golan T, Parikh S, Nordlinger A, Netti F, Sheinboim D, Dror I, Thomas L, Cosson C, Gonen P, Stanevsky Y, Brenner R, Perluk T, Frand J, Elgavish S, Nevo Y, Rahat D, Tabach Y, Khaled M, Shen-Orr SS, Levy C.

Mol Cell. 2018 Nov 1;72(3):444-456.e7. doi: 10.1016/j.molcel.2018.09.022. Epub 2018 Oct 25.

20.

Resting-State Activity in High-Order Visual Areas as a Window into Natural Human Brain Activations.

Strappini F, Wilf M, Karp O, Goldberg H, Harel M, Furman-Haran E, Golan T, Malach R.

Cereb Cortex. 2018 Nov 3. doi: 10.1093/cercor/bhy242. [Epub ahead of print]

PMID:
30395164
21.

miRNA-211 stops the clock.

Levy C, Golan T, Fisher DE.

Noncoding RNA Investig. 2018 May;2. pii: 25. doi: 10.21037/ncri.2018.04.05. Epub 2018 May 6. No abstract available.

22.

LY2495655, an antimyostatin antibody, in pancreatic cancer: a randomized, phase 2 trial.

Golan T, Geva R, Richards D, Madhusudan S, Lin BK, Wang HT, Walgren RA, Stemmer SM.

J Cachexia Sarcopenia Muscle. 2018 Oct;9(5):871-879. doi: 10.1002/jcsm.12331. Epub 2018 Jul 27.

23.

Harnessing synthetic lethality to predict the response to cancer treatment.

Lee JS, Das A, Jerby-Arnon L, Arafeh R, Auslander N, Davidson M, McGarry L, James D, Amzallag A, Park SG, Cheng K, Robinson W, Atias D, Stossel C, Buzhor E, Stein G, Waterfall JJ, Meltzer PS, Golan T, Hannenhalli S, Gottlieb E, Benes CH, Samuels Y, Shanks E, Ruppin E.

Nat Commun. 2018 Jun 29;9(1):2546. doi: 10.1038/s41467-018-04647-1.

24.

Harnessing the Perioperative Period to Improve Long-term Cancer Outcomes.

Ben-Eliyahu S, Golan T.

J Natl Cancer Inst. 2018 Oct 1;110(10):1137-1138. doi: 10.1093/jnci/djy055. No abstract available.

PMID:
29718287
25.

A new look at the International Duration Evaluation of Adjuvant therapy (IDEA) classification-Defining novel predictive and prognostic markers in stage III colon cancer.

Margalit O, Mamtani R, Yang YX, Reiss KA, Golan T, Halpern N, Aderka D, Giantonio B, Shacham-Shmueli E, Boursi B.

Eur J Cancer. 2018 Jun;96:105-110. doi: 10.1016/j.ejca.2018.03.022. Epub 2018 Apr 24.

PMID:
29698932
26.

Mutated MITF-E87R in Melanoma Enhances Tumor Progression via S100A4.

Nordlinger A, Dror S, Elkahloun A, Del Rio J, Stubbs E, Golan T, Malcov H, Pricket TD, Cronin JC, Parikh S, Labes S, Thomas L, Yankovitz G, Tabach Y, Levy C, Samuels Y, Khaled M.

J Invest Dermatol. 2018 Oct;138(10):2216-2223. doi: 10.1016/j.jid.2018.03.1524. Epub 2018 Apr 19.

27.

Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer: Phase 2 Clinical KEYNOTE-059 Trial.

Fuchs CS, Doi T, Jang RW, Muro K, Satoh T, Machado M, Sun W, Jalal SI, Shah MA, Metges JP, Garrido M, Golan T, Mandala M, Wainberg ZA, Catenacci DV, Ohtsu A, Shitara K, Geva R, Bleeker J, Ko AH, Ku G, Philip P, Enzinger PC, Bang YJ, Levitan D, Wang J, Rosales M, Dalal RP, Yoon HH.

JAMA Oncol. 2018 May 10;4(5):e180013. doi: 10.1001/jamaoncol.2018.0013. Epub 2018 May 10.

28.

Assessing the prognostic value of carcinoembryonic antigen levels in stage I and II colon cancer.

Margalit O, Mamtani R, Yang YX, Reiss KA, Golan T, Halpern N, Aderka D, Giantonio B, Shacham-Shmueli E, Boursi B.

Eur J Cancer. 2018 May;94:1-5. doi: 10.1016/j.ejca.2018.01.112. Epub 2018 Mar 20.

PMID:
29502035
29.

Recapitulating the clinical scenario of BRCA-associated pancreatic cancer in pre-clinical models.

Golan T, Stossel C, Atias D, Buzhor E, Halperin S, Cohen K, Raitses-Gurevich M, Glick Y, Raskin S, Yehuda D, Feldman A, Schvimer M, Friedman E, Karni R, Wilson JM, Denroche RE, Lungu I, Bartlett JMS, Mbabaali F, Gallinger S, Berger R.

Int J Cancer. 2018 Jul 1;143(1):179-183. doi: 10.1002/ijc.31292. Epub 2018 Feb 23.

30.

Phase 1 trial evaluating cisplatin, gemcitabine, and veliparib in 2 patient cohorts: Germline BRCA mutation carriers and wild-type BRCA pancreatic ductal adenocarcinoma.

O'Reilly EM, Lee JW, Lowery MA, Capanu M, Stadler ZK, Moore MJ, Dhani N, Kindler HL, Estrella H, Maynard H, Golan T, Segal A, Salo-Mullen EE, Yu KH, Epstein AS, Segal M, Brenner R, Do RK, Chen AP, Tang LH, Kelsen DP.

Cancer. 2018 Apr 1;124(7):1374-1382. doi: 10.1002/cncr.31218. Epub 2018 Jan 16.

31.

Amphiphilic nanocarrier-induced modulation of PLK1 and miR-34a leads to improved therapeutic response in pancreatic cancer.

Gibori H, Eliyahu S, Krivitsky A, Ben-Shushan D, Epshtein Y, Tiram G, Blau R, Ofek P, Lee JS, Ruppin E, Landsman L, Barshack I, Golan T, Merquiol E, Blum G, Satchi-Fainaro R.

Nat Commun. 2018 Jan 2;9(1):16. doi: 10.1038/s41467-017-02283-9.

32.
33.

Phase II trial of veliparib in patients with previously treated BRCA-mutated pancreas ductal adenocarcinoma.

Lowery MA, Kelsen DP, Capanu M, Smith SC, Lee JW, Stadler ZK, Moore MJ, Kindler HL, Golan T, Segal A, Maynard H, Hollywood E, Moynahan M, Salo-Mullen EE, Do RKG, Chen AP, Yu KH, Tang LH, O'Reilly EM.

Eur J Cancer. 2018 Jan;89:19-26. doi: 10.1016/j.ejca.2017.11.004. Epub 2017 Dec 8.

PMID:
29223478
34.

Expression of the DNA repair gene MLH1 correlates with survival in patients who have resected pancreatic cancer and have received adjuvant chemoradiation: NRG Oncology RTOG Study 9704.

Lawrence YR, Moughan J, Magliocco AM, Klimowicz AC, Regine WF, Mowat RB, DiPetrillo TA, Small W Jr, Simko JP, Golan T, Winter KA, Guha C, Crane CH, Dicker AP.

Cancer. 2018 Feb 1;124(3):491-498. doi: 10.1002/cncr.31058. Epub 2017 Oct 20.

35.

Direct Measurement of Nuclear Dependence of Charged Current Quasielasticlike Neutrino Interactions Using MINERvA.

Betancourt M, Ghosh A, Walton T, Altinok O, Bellantoni L, Bercellie A, Bodek A, Bravar A, Cai T, Martinez Caicedo DA, Carneiro MF, Dytman SA, Díaz GA, Felix J, Fields L, Fine R, Galindo R, Gallagher H, Ghosh A, Golan T, Gran R, Harris DA, Higuera A, Hurtado K, Kiveni M, Kleykamp J, Le T, Maher E, Manly S, Mann WA, Marshall CM, McFarland KS, McGivern CL, McGowan AM, Messerly B, Miller J, Mislivec A, Morfín JG, Mousseau J, Naples D, Nelson JK, Norrick A, Nuruzzaman, Patrick CE, Perdue GN, Ramírez MA, Ren L, Rimal D, Rodrigues PA, Ruterbories D, Schellman H, Sobczyk JT, Solano Salinas CJ, Sánchez Falero S, Valencia E, Wolcott J, Wospakrik M, Yaeggy B; MINERvA Collaboration.

Phys Rev Lett. 2017 Aug 25;119(8):082001. doi: 10.1103/PhysRevLett.119.082001. Epub 2017 Aug 25.

PMID:
28952766
36.

Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine.

Geller LT, Barzily-Rokni M, Danino T, Jonas OH, Shental N, Nejman D, Gavert N, Zwang Y, Cooper ZA, Shee K, Thaiss CA, Reuben A, Livny J, Avraham R, Frederick DT, Ligorio M, Chatman K, Johnston SE, Mosher CM, Brandis A, Fuks G, Gurbatri C, Gopalakrishnan V, Kim M, Hurd MW, Katz M, Fleming J, Maitra A, Smith DA, Skalak M, Bu J, Michaud M, Trauger SA, Barshack I, Golan T, Sandbank J, Flaherty KT, Mandinova A, Garrett WS, Thayer SP, Ferrone CR, Huttenhower C, Bhatia SN, Gevers D, Wargo JA, Golub TR, Straussman R.

Science. 2017 Sep 15;357(6356):1156-1160. doi: 10.1126/science.aah5043.

37.

Increasing suppression of saccade-related transients along the human visual hierarchy.

Golan T, Davidesco I, Meshulam M, Groppe DM, Mégevand P, Yeagle EM, Goldfinger MS, Harel M, Melloni L, Schroeder CE, Deouell LY, Mehta AD, Malach R.

Elife. 2017 Aug 29;6. pii: e27819. doi: 10.7554/eLife.27819.

38.

Cortical representation of persistent visual stimuli.

Gerber EM, Golan T, Knight RT, Deouell LY.

Neuroimage. 2017 Nov 1;161:67-79. doi: 10.1016/j.neuroimage.2017.08.028. Epub 2017 Aug 12.

39.

DNA Repair Dysfunction in Pancreatic Cancer: A Clinically Relevant Subtype for Drug Development.

Golan T, Javle M.

J Natl Compr Canc Netw. 2017 Aug;15(8):1063-1069. doi: 10.6004/jnccn.2017.0133. Review.

PMID:
28784866
40.

Short- and Long-Term Survival in Metastatic Pancreatic Adenocarcinoma, 1993-2013.

Golan T, Sella T, Margalit O, Amit U, Halpern N, Aderka D, Shacham-Shmueli E, Urban D, Lawrence YR.

J Natl Compr Canc Netw. 2017 Aug;15(8):1022-1027. doi: 10.6004/jnccn.2017.0138.

PMID:
28784864
41.

Measurement of Neutral-Current K^{+} Production by Neutrinos using MINERvA.

Marshall CM, Aliaga L, Altinok O, Bellantoni L, Bercellie A, Betancourt M, Bodek A, Bravar A, Cai T, Carneiro MF, da Motta H, Dytman SA, Díaz GA, Dunkman M, Eberly B, Endress E, Felix J, Fields L, Fine R, Gago AM, Galindo R, Gallagher H, Ghosh A, Golan T, Gran R, Harris DA, Higuera A, Hurtado K, Kleykamp J, Kordosky M, Le T, Maher E, Manly S, Mann WA, Caicedo DAM, McFarland KS, McGivern CL, McGowan AM, Messerly B, Miller J, Mislivec A, Morfín JG, Mousseau J, Naples D, Nelson JK, Norrick A, Nuruzzaman, Paolone V, Patrick CE, Perdue GN, Ramírez MA, Ransome RD, Ray H, Ren L, Rimal D, Rodrigues PA, Ruterbories D, Schmitz DW, Solano Salinas CJ, Sultana M, Sánchez Falero S, Valencia E, Walton T, Wolcott J, Wospakrik M, Yaeggy B, Zhang D; MINERvA Collaboration.

Phys Rev Lett. 2017 Jul 7;119(1):011802. doi: 10.1103/PhysRevLett.119.011802. Epub 2017 Jul 7.

PMID:
28731762
42.

Pancreatic cancer ascites xenograft-an expeditious model mirroring advanced therapeutic resistant disease.

Golan T, Stossel C, Schvimer M, Atias D, Halperin S, Buzhor E, Raitses-Gurevich M, Cohen K, Pri-Chen S, Wilson J, Denroche RE, Lungu I, Bartlett JMS, Mbabaali F, Yarden Y, Nataraj NB, Gallinger S, Berger R.

Oncotarget. 2017 Jun 20;8(25):40778-40790. doi: 10.18632/oncotarget.17253.

43.

Overall Survival and Clinical Characteristics of BRCA-Associated Cholangiocarcinoma: A Multicenter Retrospective Study.

Golan T, Raitses-Gurevich M, Kelley RK, Bocobo AG, Borgida A, Shroff RT, Holter S, Gallinger S, Ahn DH, Aderka D, Apurva J, Bekaii-Saab T, Friedman E, Javle M.

Oncologist. 2017 Jul;22(7):804-810. doi: 10.1634/theoncologist.2016-0415. Epub 2017 May 9. Review.

44.

Combined Analysis of Neutrino and Antineutrino Oscillations at T2K.

Abe K, Amey J, Andreopoulos C, Antonova M, Aoki S, Ariga A, Autiero D, Ban S, Barbi M, Barker GJ, Barr G, Barry C, Bartet-Friburg P, Batkiewicz M, Berardi V, Berkman S, Bhadra S, Bienstock S, Blondel A, Bolognesi S, Bordoni S, Boyd SB, Brailsford D, Bravar A, Bronner C, Buizza Avanzini M, Calland RG, Campbell T, Cao S, Cartwright SL, Catanesi MG, Cervera A, Checchia C, Cherdack D, Chikuma N, Christodoulou G, Clifton A, Coleman J, Collazuol G, Coplowe D, Cudd A, Dabrowska A, De Rosa G, Dealtry T, Denner PF, Dennis SR, Densham C, Dewhurst D, Di Lodovico F, Di Luise S, Dolan S, Drapier O, Duffy KE, Dumarchez J, Dziewiecki M, Emery-Schrenk S, Ereditato A, Feusels T, Finch AJ, Fiorentini GA, Friend M, Fujii Y, Fukuda D, Fukuda Y, Galymov V, Garcia A, Giganti C, Gizzarelli F, Golan T, Gonin M, Hadley DR, Haegel L, Haigh MD, Hansen D, Harada J, Hartz M, Hasegawa T, Hastings NC, Hayashino T, Hayato Y, Helmer RL, Hillairet A, Hiraki T, Hiramoto A, Hirota S, Hogan M, Holeczek J, Hosomi F, Huang K, Ichikawa AK, Ikeda M, Imber J, Insler J, Intonti RA, Ishida T, Ishii T, Iwai E, Iwamoto K, Izmaylov A, Jamieson B, Jiang M, Johnson S, Jonsson P, Jung CK, Kabirnezhad M, Kaboth AC, Kajita T, Kakuno H, Kameda J, Karlen D, Katori T, Kearns E, Khabibullin M, Khotjantsev A, Kim H, Kim J, King S, Kisiel J, Knight A, Knox A, Kobayashi T, Koch L, Koga T, Konaka A, Kondo K, Kormos LL, Korzenev A, Koshio Y, Kowalik K, Kropp W, Kudenko Y, Kurjata R, Kutter T, Lagoda J, Lamont I, Lamoureux M, Larkin E, Lasorak P, Laveder M, Lawe M, Licciardi M, Lindner T, Liptak ZJ, Litchfield RP, Li X, Longhin A, Lopez JP, Lou T, Ludovici L, Lu X, Magaletti L, Mahn K, Malek M, Manly S, Marino AD, Martin JF, Martins P, Martynenko S, Maruyama T, Matveev V, Mavrokoridis K, Ma WY, Mazzucato E, McCarthy M, McCauley N, McFarland KS, McGrew C, Mefodiev A, Metelko C, Mezzetto M, Mijakowski P, Minamino A, Mineev O, Mine S, Missert A, Miura M, Moriyama S, Mueller TA, Myslik J, Nakadaira T, Nakahata M, Nakamura KG, Nakamura K, Nakamura KD, Nakanishi Y, Nakayama S, Nakaya T, Nakayoshi K, Nantais C, Nielsen C, Nirkko M, Nishikawa K, Nishimura Y, Novella P, Nowak J, O'Keeffe HM, Okumura K, Okusawa T, Oryszczak W, Oser SM, Ovsyannikova T, Owen RA, Oyama Y, Palladino V, Palomino JL, Paolone V, Patel ND, Paudyal P, Pavin M, Payne D, Perkin JD, Petrov Y, Pickard L, Pickering L, Pinzon Guerra ES, Pistillo C, Popov B, Posiadala-Zezula M, Poutissou JM, Poutissou R, Przewlocki P, Quilain B, Radermacher T, Radicioni E, Ratoff PN, Ravonel M, Rayner MA, Redij A, Reinherz-Aronis E, Riccio C, Rodrigues PA, Rondio E, Rossi B, Roth S, Rubbia A, Rychter A, Sakashita K, Sánchez F, Scantamburlo E, Scholberg K, Schwehr J, Scott M, Seiya Y, Sekiguchi T, Sekiya H, Sgalaberna D, Shah R, Shaikhiev A, Shaker F, Shaw D, Shiozawa M, Shirahige T, Short S, Smy M, Sobczyk JT, Sobel H, Sorel M, Southwell L, Steinmann J, Stewart T, Stowell P, Suda Y, Suvorov S, Suzuki A, Suzuki SY, Suzuki Y, Tacik R, Tada M, Takeda A, Takeuchi Y, Tanaka HK, Tanaka HA, Terhorst D, Terri R, Thakore T, Thompson LF, Tobayama S, Toki W, Tomura T, Touramanis C, Tsukamoto T, Tzanov M, Uchida Y, Vagins M, Vallari Z, Vasseur G, Vladisavljevic T, Wachala T, Walter CW, Wark D, Wascko MO, Weber A, Wendell R, Wilkes RJ, Wilking MJ, Wilkinson C, Wilson JR, Wilson RJ, Wret C, Yamada Y, Yamamoto K, Yamamoto M, Yanagisawa C, Yano T, Yen S, Yershov N, Yokoyama M, Yoshida K, Yuan T, Yu M, Zalewska A, Zalipska J, Zambelli L, Zaremba K, Ziembicki M, Zimmerman ED, Zito M, Żmuda J; T2K Collaboration.

Phys Rev Lett. 2017 Apr 14;118(15):151801. doi: 10.1103/PhysRevLett.118.151801. Epub 2017 Apr 10.

45.

Exclusive destruction of mitotic spindles in human cancer cells.

Visochek L, Castiel A, Mittelman L, Elkin M, Atias D, Golan T, Izraeli S, Peretz T, Cohen-Armon M.

Oncotarget. 2017 Mar 28;8(13):20813-20824. doi: 10.18632/oncotarget.15343.

46.

Overall survival and clinical characteristics of BRCA mutation carriers with stage I/II pancreatic cancer.

Golan T, Sella T, O'Reilly EM, Katz MH, Epelbaum R, Kelsen DP, Borgida A, Maynard H, Kindler H, Friedmen E, Javle M, Gallinger S.

Br J Cancer. 2017 Mar 14;116(6):697-702. doi: 10.1038/bjc.2017.19. Epub 2017 Feb 9.

47.

Human intracranial recordings link suppressed transients rather than 'filling-in' to perceptual continuity across blinks.

Golan T, Davidesco I, Meshulam M, Groppe DM, Mégevand P, Yeagle EM, Goldfinger MS, Harel M, Melloni L, Schroeder CE, Deouell LY, Mehta AD, Malach R.

Elife. 2016 Sep 29;5. pii: e17243. doi: 10.7554/eLife.17243.

48.

Evidence for Neutral-Current Diffractive π^{0} Production from Hydrogen in Neutrino Interactions on Hydrocarbon.

Wolcott J, Aliaga L, Altinok O, Bercellie A, Betancourt M, Bodek A, Bravar A, Budd H, Cai T, Carneiro MF, Chvojka J, da Motta H, Devan J, Dytman SA, Díaz GA, Eberly B, Endress E, Felix J, Fields L, Fine R, Galindo R, Gallagher H, Golan T, Gran R, Harris DA, Higuera A, Hurtado K, Kiveni M, Kleykamp J, Kordosky M, Le T, Maher E, Manly S, Mann WA, Marshall CM, Martinez Caicedo DA, McFarland KS, McGivern CL, McGowan AM, Messerly B, Miller J, Mislivec A, Morfín JG, Mousseau J, Naples D, Nelson JK, Norrick A, Nuruzzaman, Osta J, Paolone V, Park J, Patrick CE, Perdue GN, Rakotondravohitra L, Ramirez MA, Ray H, Ren L, Rimal D, Rodrigues PA, Ruterbories D, Schellman H, Schmitz DW, Solano Salinas CJ, Sánchez Falero S, Tagg N, Tice BG, Valencia E, Walton T, Wospakrik M, Zhang D; MINERvA Collaboration.

Phys Rev Lett. 2016 Sep 9;117(11):111801. doi: 10.1103/PhysRevLett.117.111801. Epub 2016 Sep 7.

PMID:
27661679
49.

Melanoma miRNA trafficking controls tumour primary niche formation.

Dror S, Sander L, Schwartz H, Sheinboim D, Barzilai A, Dishon Y, Apcher S, Golan T, Greenberger S, Barshack I, Malcov H, Zilberberg A, Levin L, Nessling M, Friedmann Y, Igras V, Barzilay O, Vaknine H, Brenner R, Zinger A, Schroeder A, Gonen P, Khaled M, Erez N, Hoheisel JD, Levy C.

Nat Cell Biol. 2016 Sep;18(9):1006-17. doi: 10.1038/ncb3399. Epub 2016 Aug 22.

PMID:
27548915
50.

Evidence of Coherent K^{+} Meson Production in Neutrino-Nucleus Scattering.

Wang Z, Marshall CM, Aliaga L, Altinok O, Bellantoni L, Bercellie A, Betancourt M, Bodek A, Bravar A, Budd H, Cai T, Carneiro MF, da Motta H, Dytman SA, Díaz GA, Eberly B, Endress E, Felix J, Fields L, Fine R, Galindo R, Gallagher H, Ghosh A, Golan T, Gran R, Harris DA, Higuera A, Hurtado K, Kiveni M, Kleykamp J, Kordosky M, Le T, Maher E, Manly S, Mann WA, Martinez Caicedo DA, McFarland KS, McGivern CL, McGowan AM, Messerly B, Miller J, Mislivec A, Morfín JG, Mousseau J, Naples D, Nelson JK, Norrick A, Nuruzzaman, Paolone V, Park J, Patrick CE, Perdue GN, Rakotondravohitra L, Ramirez MA, Ransome RD, Ray H, Ren L, Rimal D, Rodrigues PA, Ruterbories D, Schellman H, Schmitz DW, Simon C, Solano Salinas CJ, Tice BG, Valencia E, Walton T, Wolcott J, Wospakrik M, Zavala G, Zhang D; MINERvA Collaboration.

Phys Rev Lett. 2016 Aug 5;117(6):061802. doi: 10.1103/PhysRevLett.117.061802. Epub 2016 Aug 5.

PMID:
27541459

Supplemental Content

Support Center